Last reviewed · How we verify

NCT06323083

The Effect of Emotional Freedom Technique on Perceived Stress and General Self-Efficacy in Nursing Students

Completed NA Last updated 21 March 2024
What this trial tests

NA trial testing Emotional Freedom Technique in Emotion Regulation in 50 participants. Completed in 30 June 2023.

Timeline
7 November 2022
Primary endpoint
28 November 2022
30 June 2023

Quick facts

Lead sponsorSelcuk University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment50
Start date7 November 2022
Primary completion28 November 2022
Estimated completion30 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Selcuk University

Who can join

Adults 18 to 40, female only, with Emotion Regulation or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was conducted to determine the effect of Emotional Freedom Technique (EFT) on perceived stress and general self-efficacy in obstetrics and gynecology nursing lesson in undergraduate nursing students with fear of birth. The samples were applied to undergraduate nursing students satisfying the research criteria in a state university nursing faculty in Konya at November 2022.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Emotional Freedom Technique

Trials testing the same drug.

Other recruiting trials for Emotion Regulation

Currently open trials in the same condition.

Other Selcuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06323083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing